Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial
PaperCitations, authors & open-access status
Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 197 citations, 2023 year and bronze oa status.
197
Citations
2023
Year
bronze
OA Status